Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10487) 10487
Newspaper Article (943) 943
Publication (391) 391
Book Review (150) 150
Magazine Article (97) 97
Web Resource (67) 67
Book Chapter (52) 52
Newsletter (34) 34
Trade Publication Article (33) 33
Dissertation (20) 20
Book / eBook (13) 13
Report (5) 5
Conference Proceeding (4) 4
Paper (3) 3
Government Document (2) 2
Reference (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8243) 8243
female (5330) 5330
vomiting (4532) 4532
male (4097) 4097
vomiting - prevention & control (3652) 3652
adult (3615) 3615
nausea (3572) 3572
middle aged (3278) 3278
index medicus (2902) 2902
antiemetics - therapeutic use (2842) 2842
vomiting - chemically induced (2595) 2595
nausea - prevention & control (2341) 2341
prevention (2250) 2250
aged (2163) 2163
anesthesiology (1899) 1899
postoperative nausea and vomiting - prevention & control (1868) 1868
nausea - chemically induced (1826) 1826
chemotherapy (1799) 1799
double-blind method (1723) 1723
oncology (1575) 1575
ondansetron (1485) 1485
antineoplastic agents - adverse effects (1442) 1442
surgery (1429) 1429
adolescent (1418) 1418
treatment outcome (1232) 1232
child (1220) 1220
antiemetics - administration & dosage (1178) 1178
prospective studies (1164) 1164
double-blind (1142) 1142
cancer (1083) 1083
dexamethasone (1019) 1019
pain (983) 983
anesthesia (968) 968
risk factors (939) 939
vomiting - etiology (894) 894
child, preschool (880) 880
antiemetics (846) 846
efficacy (822) 822
ondansetron - therapeutic use (816) 816
drug therapy, combination (810) 810
children (795) 795
neoplasms - drug therapy (755) 755
pediatrics (736) 736
patients (726) 726
postoperative nausea and vomiting (715) 715
emesis (692) 692
care and treatment (691) 691
vomiting - drug therapy (688) 688
postoperative nausea (682) 682
pharmacology & pharmacy (671) 671
pain, postoperative - prevention & control (654) 654
postoperative complications - prevention & control (654) 654
antiemetics - adverse effects (652) 652
cisplatin - adverse effects (649) 649
dexamethasone - therapeutic use (642) 642
time factors (639) 639
metoclopramide (625) 625
animals (622) 622
diarrhea (606) 606
research (601) 601
medicine & public health (583) 583
health aspects (582) 582
nausea - drug therapy (568) 568
medicine, general & internal (565) 565
clinical trials (556) 556
pregnancy (555) 555
aged, 80 and over (544) 544
infant (542) 542
young adult (540) 540
granisetron (526) 526
analysis (505) 505
droperidol (503) 503
incidence (500) 500
antineoplastic combined chemotherapy protocols - adverse effects (499) 499
medicine (496) 496
drug therapy (492) 492
nausea - etiology (481) 481
metoclopramide - therapeutic use (468) 468
dose-response relationship, drug (466) 466
serotonin antagonists - therapeutic use (464) 464
dexamethasone - administration & dosage (453) 453
cisplatin (446) 446
nursing (445) 445
prophylaxis (441) 441
studies (436) 436
drug dosages (425) 425
retrospective studies (422) 422
ondansetron - administration & dosage (421) 421
postoperative nausea and vomiting - epidemiology (417) 417
management (416) 416
drug administration schedule (414) 414
complications and side effects (408) 408
aprepitant (401) 401
abridged index medicus (399) 399
administration, oral (391) 391
analgesia (383) 383
postoperative nausea and vomiting - etiology (374) 374
injections, intravenous (373) 373
palonosetron (373) 373
cancer therapies (372) 372
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10607) 10607
German (266) 266
Japanese (214) 214
French (158) 158
Spanish (84) 84
Chinese (71) 71
Italian (69) 69
Russian (61) 61
Korean (51) 51
Polish (27) 27
Turkish (24) 24
Danish (22) 22
Portuguese (17) 17
Hungarian (13) 13
Norwegian (9) 9
Swedish (9) 9
Dutch (7) 7
Serbian (6) 6
Czech (5) 5
Hebrew (4) 4
Romanian (4) 4
Ukrainian (4) 4
Croatian (3) 3
Persian (3) 3
Arabic (2) 2
Bulgarian (2) 2
Finnish (2) 2
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy
by Kakuru, Abel and Jagannathan, Prasanna and Muhindo, Mary K and Natureeba, Paul and Awori, Patricia and Nakalembe, Miriam and Opira, Bishop and Olwoch, Peter and Ategeka, John and Nayebare, Patience and Clark, Tamara D and Feeney, Margaret E and Charlebois, Edwin D and Rizzuto, Gabrielle and Muehlenbachs, Atis and Havlir, Diane V and Kamya, Moses R and Dorsey, Grant
The New England Journal of Medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 10, pp. 928 - 939
Malaria causes complications during pregnancy, and its prevention is more challenging in the setting of drug-resistant parasites. This trial from Uganda, where... 
WOMEN | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | LOW-BIRTH-WEIGHT | MALAWI | INFECTION | PLACEBO-CONTROLLED TRIAL | DRUG-RESISTANCE | ANEMIA | INTERMITTENT SULFADOXINE-PYRIMETHAMINE | UGANDA | Humans | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Incidence | Young Adult | Malaria - epidemiology | Sulfadoxine - therapeutic use | Adult | Female | Parasitemia - epidemiology | Drug Resistance | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Double-Blind Method | Drug Administration Schedule | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Malaria - prevention & control | Pregnancy | Vomiting - chemically induced | Adolescent | Pregnancy Complications, Parasitic - prevention & control | Uganda | Artemisinins - adverse effects | Drug Combinations | Pregnancy Outcome | Quinolines - adverse effects | Care and treatment | Usage | Malaria | Pregnant women | Pyrimethamine | Clinical trials | Dosage and administration | Health aspects | Dihydroartemisinin | Adolescence | Preventive medicine | Studies | Placenta | Womens health | Vomiting | Human immunodeficiency virus--HIV | Sulfadoxine | Parasitemia | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
by Navari, Rudolph M and Qin, Rui and Ruddy, Kathryn J and Liu, Heshan and Powell, Steven F and Bajaj, Madhuri and Dietrich, Leah and Biggs, David and Lafky, Jacqueline M and Loprinzi, Charles L
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 2, pp. 134 - 142
The addition of olanzapine to a neurokinin receptor blocker, a serotonin receptor blocker, and dexamethasone markedly improved the control of nausea and... 
TRIAL | MEDICINE, GENERAL & INTERNAL | NETUPITANT | EFFICACY | MODERATELY EMETOGENIC CHEMOTHERAPY | SAFETY | DOUBLE-BLIND | PALONOSETRON | ROLAPITANT | COMBINATION | CANCER | Aprepitant | Olanzapine | Double-Blind Method | Nausea - chemically induced | Humans | Middle Aged | Male | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Aged | Benzodiazepines - adverse effects | Drug Therapy, Combination | Benzodiazepines - therapeutic use | Vomiting - prevention & control | Morpholines - therapeutic use | Complications and side effects | Care and treatment | Chemotherapy | Vomiting | Dosage and administration | Nausea | Cancer | Heart attacks | Dexamethasone | Serotonin | Nervous system | Doxorubicin | Cisplatin | Studies | Psychotropic drugs | Cyclophosphamide | Diabetes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Monoclonal antibodies for migraine prevention progress, but not a panacea
by Loder, Elizabeth W and Robbins, Matthew S
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 19, pp. 1985 - 1987
The article discusses the findings of a study to evaluate the efficacy of fremanezumab as a form of treatment for the prevention of episodic migraine in... 
MEDICINE, GENERAL & INTERNAL | PREVALENCE | EPISODIC MIGRAINE | FREMANEZUMAB | Calcitonin Gene-Related Peptide | Migraine Disorders | Antibodies, Monoclonal | Prevention | Treatment outcome | Care and treatment | Migraine | Analysis | Monoclonal antibodies | Dosage and administration | Disease prevention | Headache | Vomiting | Neurological complications | Nausea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE
by Steven Grunberg and Daniel Chua and Anish Maru and José Dinis and Suzanne DeVandry and Judith A. Boice and James S. Hardwick and Elizabeth Beckford and Arlene Taylor and Alexandra Carides and Fausto Roila and Jørn Herrstedt
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 11, pp. 1495 - 1501
Purpose Addition of aprepitant, a neurokinin-1 receptor antagonist (NK1RA), to an ondansetron and dexamethasone regimen improves prevention of... 
ORAL NEUROKININ-1 ANTAGONIST | DEXAMETHASONE | ANTIEMETICS | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | CASOPITANT MESYLATE | PATIENTS RECEIVING CISPLATIN | PLACEBO-CONTROLLED TRIAL | DELAYED NAUSEA | MULTIPLE CYCLES | RECEPTOR ANTAGONIST APREPITANT | Dexamethasone - administration & dosage | Double-Blind Method | Drug Administration Schedule | Nausea - chemically induced | Humans | Middle Aged | Morpholines - administration & dosage | Antiemetics - administration & dosage | Ondansetron - administration & dosage | Male | Treatment Outcome | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Ondansetron - therapeutic use | Antiemetics - therapeutic use | Aged, 80 and over | Cisplatin - adverse effects | Adult | Female | Aged | Vomiting - prevention & control | Morpholines - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Safety, pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (CereniaTM) for the prevention of emesis and motion sickness in cats
by HICKMAN, M. A and COX, S. R and MAHABIR, S and MISKELL, C and LIN, J and BUNGER, A and McCALL, R. B
Journal of Veterinary Pharmacology and Therapeutics, ISSN 0140-7783, 06/2008, Volume 31, Issue 3, pp. 220 - 229
The present study characterizes the safety, pharmacokinetics, and anti‐emetic effects of the selective NK‐1 receptor antagonist maropitant in the cat. Safety... 
CP-99,994 | CISPLATIN | DOGS | FERRETS | PHARMACOLOGY & PHARMACY | VETERINARY SCIENCES | NK1 RECEPTOR | ANTIEMETIC EFFICACY | BRAIN | SUBSTANCE | Cats | Motion Sickness - veterinary | Male | Metabolic Clearance Rate | Vomiting - veterinary | Vomiting - chemically induced | Motion Sickness - etiology | Animals | Quinuclidines - therapeutic use | Female | Motion Sickness - prevention & control | Vomiting - prevention & control | Neurokinin-1 Receptor Antagonists | Quinuclidines - adverse effects | Quinuclidines - pharmacokinetics | Safety and security measures | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
by Bošnjak, Snežana M and Gralla, Richard J and Schwartzberg, Lee
Supportive Care in Cancer, ISSN 0941-4355, 5/2017, Volume 25, Issue 5, pp. 1661 - 1671
Chemotherapy-induced nausea (CIN) has a significant negative impact on the quality of life of cancer patients. The use of 5-hydroxytryptamine-3 (5-HT3)... 
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Nursing Research | NK 1 receptor antagonist | Chemotherapy-induced nausea (CIN) | Oncology | Antiemetic guidelines | receptor antagonist | PALONOSETRON NEPA | PHASE-III | ANTIEMETIC THERAPY | INDUCED DELAYED EMESIS | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | FIXED-DOSE COMBINATION | RADIOTHERAPY-INDUCED NAUSEA | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | NK1 receptor antagonist | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Quality of Life - psychology | Prevention | Medical colleges | Chemotherapy | Dexamethasone | Nausea | Patient compliance | Cancer | Side effects | Antagonist drugs | Clinical outcomes | Meta-analysis | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference
by Roila, F and Herrstedt, J and Aapro, M and Gralla, R.J and Einhorn, L.H and Ballatori, E and Bria, E and Clark-Snow, R.A and Espersen, B.T and Feyer, P and Grunberg, S.M and Hesketh, P.J and Jordan, K and Kris, M.G and Maranzano, E and Molassiotis, A and Morrow, G and Olver, I and Rapoport, B.L and Rittenberg, C and Saito, M and Tonato, M and Warr, D and ESMO MASCC Guidelines Working Grp and ESMO/MASCC Guidelines Working Group and On behalf of the ESMO/MASCC Guidelines Working Group
Annals of Oncology, ISSN 0923-7534, 05/2010, Volume 21, Issue 5, pp. v232 - v243
BREAST-CANCER | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | CASOPITANT MESYLATE | PHASE-III | DOUBLE-BLIND | APREPITANT | PLACEBO-CONTROLLED TRIAL | HIGH-DOSE CISPLATIN | NEUROKININ-1 RECEPTOR ANTAGONIST | ACUTE EMESIS | Nausea - prevention & control | Vomiting - chemically induced | Nausea - chemically induced | Humans | Vomiting - drug therapy | Nausea - drug therapy | Vomiting - prevention & control | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference
by Roila, Fausto and Aapro, Matti and Ballatori, Enzo and Borjeson, Sussanne and Clark-Snow, Rebecca A and Del Favero, Albano and Einhorn, Lawrence H and Feyer, Petra and Gralla, Richard J and Grunberg, Steven M and Herrstedt, Jorn and Hesketh, Paul J and Kaiser, Rolf and Koeller, Jim and Kris, Mark G and Maranzano, Ernesto and Molassiotis, Alexander and Olver, Ian and Osoba, David and Rapoport, Bernardo L and Rittenberg, Cynthia and Tonato, Maurizio and Warr, David and MASCC and Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer and The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)
Annals of Oncology, ISSN 0923-7534, 01/2006, Volume 17, Issue 1, pp. 20 - 28
Background: In the late 1990s, several professional organizations convened antiemetic guideline groups and published the findings of these expert panels. Each... 
Aprepitant | 5-HT3-receptor antagonists | Acute emesis | Dexamethasone | Metoclopramide | Delayed emesis | dexamethasone | INDUCED NAUSEA | acute emesis | PHASE-III | ONDANSETRON PLUS DEXAMETHASONE | ORAL NK1 ANTAGONIST | CLINICAL CHARACTERISTICS | CISPLATIN-BASED CHEMOTHERAPY | aprepitant | delayed emesis | metoclopramide | INDUCED DELAYED EMESIS | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Vomiting - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neoplasms - radiotherapy | Radiotherapy - adverse effects | Vomiting - prevention & control | Neoplasms - drug therapy | Practice Guidelines as Topic | Naturvetenskap | Natural Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Low-dose droperidol (≤1 mg or ≤15 μg kg−1) for the prevention of postoperative nausea and vomiting in adults: quantitative systematic review of randomised controlled trials
by Schaub, Isabelle and Lysakowski, Christopher and Elia, Nadia and Tramèr, Martin R
European Journal of Anaesthesiology, ISSN 0265-0215, 06/2012, Volume 29, Issue 6, pp. 286 - 294
CONTEXTDroperidol is widely used for the prevention of postoperative nausea and vomiting (PONV) in European countries. It is unclear how efficacious low-dose... 
Nausea | Vomiting | Droperidol | Emesis | INTERVAL PROLONGATION | PLACEBO | droperidol | EFFICACY | ONDANSETRON | emesis | QTC INTERVAL | METOCLOPRAMIDE | COMBINATION | GENERAL-ANESTHESIA | nausea | PROPHYLACTIC ANTIEMETIC THERAPY | ANESTHESIOLOGY | LAPAROSCOPY | vomiting | Droperidol - adverse effects | Droperidol - therapeutic use | Humans | Antiemetics - administration & dosage | Treatment Outcome | Statistics as Topic | Postoperative Nausea and Vomiting - prevention & control | Randomized Controlled Trials as Topic | Dose-Response Relationship, Drug | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Droperidol - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
by Ataga, Kenneth I and Kutlar, Abdullah and Kanter, Julie and Liles, Darla and Cancado, Rodolfo and Friedrisch, João and Guthrie, Troy H and Knight-Madden, Jennifer and Alvarez, Ofelia A and Gordeuk, Victor R and Gualandro, Sandra and Colella, Marina P and Smith, Wally R and Rollins, Scott A and Stocker, Jonathan W and Rother, Russell P
The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 5, pp. 429 - 439
In this yearlong trial involving patients with sickle cell disease, crizanlizumab, an antibody to P-selectin, was associated with a 45% lower rate of pain... 
ADHESION | MEDICINE, GENERAL & INTERNAL | LEUKOCYTES | VASOOCCLUSION | ERYTHROCYTES | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ENDOTHELIUM | HYDROXYUREA | P-SELECTIN | ANEMIA | FLOW | P-Selectin - antagonists & inhibitors | Double-Blind Method | Pain - prevention & control | Anemia, Sickle Cell - complications | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Anemia, Sickle Cell - drug therapy | Young Adult | Adolescent | Pain - etiology | Quality of Life | Adult | Female | Hydroxyurea - therapeutic use | Drug Therapy, Combination | P-Selectin - immunology | Viral antibodies | Prevention | Usage | Care and treatment | Safety and security measures | Sickle cell anemia | Antibodies | Dosage and administration | Patients | Occlusion | Spleen | Chest | Arthralgia | Body weight | Liver | Neutrophils | Diarrhea | Hydroxyurea | Inflammation | Pruritus | Cell interactions | Endothelial cells | Endothelium | Pain | Blood platelets | Vomiting | Transgenic animals | Hemoglobin | Sickle cell disease | P-selectin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Medical follow up after bariatric surgery: nutritional and drug issues General recommendations for the prevention and treatment of nutritional deficiencies
by Ziegler, O and Sirveaux, M.A and Brunaud, L and Reibel, N and Quilliot, D
Diabetes and Metabolism, ISSN 1262-3636, 2009, Volume 35, Issue 6, pp. 544 - 557
Abstract This review is an update of the long-term follow-up of nutritional and metabolic issues following bariatric surgery, and also discusses the most... 
Internal Medicine | Endocrinology & Metabolism | Therapeutic patient education | Chirurgie bariatrique | anneau gastrique adjustable | revue | Bariatric surgery | Gastric bypass | Vertical banded gastroplasty | Review | supplémentation | Guidelines | carence nutritionnelle | court circuit gastrique | éducation thérapeutique du patient | recommandations | gastroplastie verticale calibre | Adjustable gastric band | Supplementation | gastrectomie en gouttière | Nutritional deficiency | Sleeve gastrectomy | DIAGNOSIS | HYPERINSULINEMIC HYPOGLYCEMIA | WEIGHT-LOSS | NEUROLOGIC COMPLICATIONS | LONG-TERM MORTALITY | WERNICKES ENCEPHALOPATHY | GASTRIC BYPASS-SURGERY | GASTROPLASTY | ENDOCRINOLOGY & METABOLISM | GALLSTONE FORMATION | MORBID-OBESITY | Gallstones - prevention & control | Obesity, Morbid - surgery | Humans | Malnutrition - etiology | Patient Care Team | Diarrhea - prevention & control | Anemia, Iron-Deficiency - prevention & control | Gastroplasty - adverse effects | Malnutrition - prevention & control | Gastrectomy - adverse effects | Adult | Female | Bariatric Surgery - adverse effects | Protein-Energy Malnutrition - etiology | Obesity, Morbid - metabolism | Vomiting - prevention & control | Dehydration - prevention & control | Bariatric Surgery - psychology | Malabsorption Syndromes - prevention & control | Pregnancy Complications - etiology | Anemia, Iron-Deficiency - etiology | Gallstones - etiology | Feeding and Eating Disorders - complications | Gastric Bypass - adverse effects | Protein-Energy Malnutrition - prevention & control | Avitaminosis - etiology | Avitaminosis - prevention & control | Dehydration - etiology | Pregnancy | Malabsorption Syndromes - etiology | Weight Loss | Adolescent | Vomiting - etiology | Diarrhea - etiology | Pregnancy Complications - prevention & control | Nutritional Support | Bariatric Surgery - methods | Population Surveillance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Improved Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with Palonosetron, a Pharmacologically Novel 5-HT3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
by Eisenberg, Peter and Figueroa-Vadillo, Jazmin and Zamora, Rosalio and Charu, Veena and Hajdenberg, Julio and Cartmell, Alan and Macciocchi, Alberto and Grunberg, Steven and 99-04 Palonosetron Study Group
Cancer, ISSN 0008-543X, 12/2003, Volume 98, Issue 11, pp. 2473 - 2482
BACKGROUND. Palonosetron, a highly selective and potent 5-HT3 receptor antagonist with a strong binding affinity and a long plasma elimination half-life... 
Dolasetron | 5-HT | receptor antagonist | Antiemetic | Chemotherapy-induced nausea and vomiting | Palonosetron | SELECTIVE ANTAGONIST | POTENT | ONCOLOGY | dolasetron | GUIDELINES | antiemetic | palonosetron | 5-HT3 receptor antagonist | chemotherapy-induced nausea and vomiting | Quinolizines - therapeutic use | Isoquinolines - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Isoquinolines - pharmacology | Quinuclidines - therapeutic use | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Female | Indoles - pharmacology | Quinolizines - adverse effects | Vomiting - prevention & control | Quinuclidines - adverse effects | Severity of Illness Index | Double-Blind Method | Quinuclidines - pharmacology | Treatment Outcome | Quinolizines - pharmacology | Neoplasms - drug therapy | Vomiting - chemically induced | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Isoquinolines - therapeutic use | Indoles - therapeutic use | Aged | Infusions, Intravenous | Antiemetics - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Non-needle acupoint stimulation for prevention of nausea and vomiting after breast surgery: A meta-analysis
by Sun, R and Dai, W and Liu, Y and Liu, CL and Liu, YN and Gong, Y and Sun, XH and Shi, TY and Song, MZ
MEDICINE, ISSN 0025-7974, 03/2019, Volume 98, Issue 10, p. e14713
Background:Breast disease has been a global serious health problem, among women. Surgery is the main treatment for the patients suffering from breast disease.... 
PONV | MANAGEMENT | QUALITY | ACUPUNCTURE | meta-analysis | ONDANSETRON | RISK | ACUPRESSURE | nausea | POSTOPERATIVE NAUSEA | MEDICINE, GENERAL & INTERNAL | IMPACT | PAIN | non-needling stimulation | acupoint | breast | vomiting | Humans | Breast Diseases - surgery | Acupuncture Points | Female | Treatment Outcome | Postoperative Nausea and Vomiting - etiology | Transcutaneous Electric Nerve Stimulation - methods | Postoperative Nausea and Vomiting - prevention & control | Surgical Procedures, Operative - adverse effects | Prevention | Complications and side effects | Care and treatment | Acupuncture points | Vomiting | Complications | Surgery | Nausea | Breast diseases | Risk factors | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
by Paul J. Hesketh and Steven M. Grunberg and Richard J. Gralla and David G. Warr and Fausto Roila and Ronald de Wit and Sant P. Chawla and Alexandra D. Carides and Juliana Ianus and Mary E. Elmer and Judith K. Evans and Klaus